Digital therapeutics (DTx) are changing the healthcare delivery system with evidence-based technologies that improve patient outcomes.Learn About DTx
"After using Freespira I have been able to manage my stress and anxiety, and panic attacks feel like a distant memory. I'm excited to help others live a panic-free life as well."
Talia, United States
“JOGO has reduced my tremors considerably. I am able to sleep better after using JOGO before going to bed.”
Hugh, United States
“Dario has helped me manage my diabetes, because I now know how my body reacts to different foods and meals. Before Dario, my A1c was 9.7. Now its 5.7.”
Richard J., United States
The ‘DTx Value Assessment & Integration Guide’ provides a first ever industry framework to streamline the process of bringing safe and effective digital therapeutics into clinical use.
The Guide provides the building blocks of DTx product review and economic assessment pathways and serves as a tool for healthcare decision makers (HCDMs) and DTx manufacturers to use in assessing baseline information about DTx products, their value, and their impact in real-world settings.Learn More about the DTx Value Guide
The Digital Therapeutics Alliance is a global non-profit trade association of industry leaders and stakeholders engaged in the advancement of evidence-driven digital therapeutics.
DTA works to broaden the understanding, adoption, and integration of clinically evaluated digital therapeutics into healthcare through education, advocacy, and cross-industry collaboration. DTA maintains an international industry presence and is proud to work with members from 17 countries spread across five continents.Join DTA's Global Efforts
Member organizations play a critical role in transforming healthcare by delivering an impressive array of therapeutic interventions that improve clinical and health economic outcomes. Learn more about DTA and member company contributions.